VF
NGNE icon

Virtu Financial’s Neurogene NGNE Stock Holding History

Virtu Financial’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,782
Closed -$37K – 2052
2022
Q2 		$37K Buy
+1,782
New +$43.5K ﹤0.01% 1198
2019
Q4 		– Sell
-998
Closed -$57K – 1710
2019
Q3 		$57K Buy
+998
New +$60.9K ﹤0.01% 1174
2018
Q3 		– Sell
-774
Closed -$41K – 1966
2018
Q2 		$41K Buy
+774
New +$202K ﹤0.01% 1791

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Virtu Financial's NGNE Position: Q3 2022 in Review

Virtu Financial sold out of Neurogene (NGNE) in Q3 2022, closing a stake of 1,782 shares — an estimated $37K sold.

Virtu Financial first reported a position in NGNE in Q2 2018 and held it in 3 quarters. The position peaked at $57K in Q3 2019. 52 funds tracked by Wall St. Rank hold NGNE as of Q3 2022.

  • Virtu Financial reported no remaining Neurogene position as of Q3 2022 after selling out during the quarter.
  • Virtu Financial sold 1,782 Neurogene shares in Q3 2022, an estimated $37K.
  • Virtu Financial first reported a position in Neurogene in Q2 2018 and held it in 3 quarters.
  • Virtu Financial's Neurogene position peaked at $57K in Q3 2019.
  • 52 funds tracked by Wall St. Rank held Neurogene as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.